FDA cleared the Reprocessed AcuNav CRYSTAL Ultrasound Catheter 9F x 90 CM, For Use on Siemens System (R11510825); Reprocessed AcuNav CRYSTAL Ultrasound Catheter 9F x 90 CM, For Use on GE System (R11657484); Reprocessed SOUNDSTAR CRYSTAL Ultrasound Catheter 9F x 90 CM, For Use on Siemens System (R11510826); Reprocessed SOUNDSTAR CRYSTAL Ultrasound Catheter 9F x 90 CM, For Use on GE System (R11657485) from Sterilmed, Inc. on Jun 29, 2026 under K254149, a traditional 510(k). The device falls under product code OWQ, Reprocessed Intravascular Ultrasound Catheter, regulated at 21 CFR 870.1200 as a Class 2 device. The review panel was Cardiovascular.
FDA logged the submission as received on Dec 22, 2025. The decision came 189 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.
This is the only decision on file for Sterilmed, Inc. in the last 12 months of the tracker.
Questions & Answers
What did FDA clear under K254149?
K254149 is the FDA 510(k) for Reprocessed AcuNav CRYSTAL Ultrasound Catheter 9F x 90 CM, For Use on Siemens System (R11510825); Reprocessed AcuNav CRYSTAL Ultrasound Catheter 9F x 90 CM, For Use on GE System (R11657484); Reprocessed SOUNDSTAR CRYSTAL Ultrasound Catheter 9F x 90 CM, For Use on Siemens System (R11510826); Reprocessed SOUNDSTAR CRYSTAL Ultrasound Catheter 9F x 90 CM, For Use on GE System (R11657485), submitted by Sterilmed, Inc.. FDA's decision date was Jun 29, 2026, under product code OWQ (Reprocessed Intravascular Ultrasound Catheter).
Who makes the Reprocessed AcuNav CRYSTAL Ultrasound Catheter 9F x 90 CM, For Use on Siemens System (R11510825); Reprocessed AcuNav CRYSTAL Ultrasound Catheter 9F x 90 CM, For Use on GE System (R11657484); Reprocessed SOUNDSTAR CRYSTAL Ultrasound Catheter 9F x 90 CM, For Use on Siemens System (R11510826); Reprocessed SOUNDSTAR CRYSTAL Ultrasound Catheter 9F x 90 CM, For Use on GE System (R11657485)?
Sterilmed, Inc., based in Plymouth, MN, is the applicant of record for K254149.
How long did the K254149 review take?
FDA received the submission on Dec 22, 2025 and issued its decision on Jun 29, 2026, 189 days later.